Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™
Clinical trial NCT02254304 · COMPLETED
Trial details
- NCT number
- NCT02254304
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-31
- Primary completion
- 2016-08-20
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.